• OPEN AN ACCOUNT
Indian Indices
Sensex
76,570.35 -373.93
( -0.49%)
Global Indices
Nasdaq
52,794.59 -412.31
(-0.77%)
Dow Jones
7,653.60 -53.54
(-0.69%)
Hang Seng
64,415.54 -1,799.80
(-2.72%)
Nikkei 225
10,761.93 -27.35
(-0.25%)
Forex
USD-INR
95.24 -0.24
(-0.25%)
EUR-INR
110.49 -0.08
(-0.07%)
GBP-INR
128.99 -0.20
(-0.15%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Natco Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524816
INE987B01026
477.507017
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NATCOPHARM
17.05
15211.8
EPS(TTM)
Face Value()
Div & Yield %
49.8
2
0.59
 

infomedia press ltd
Premier reports consolidated net loss of Rs 1.76 crore in the March 2026 quarter
May 28,2026
Net Loss of Premier reported to Rs 1.76 crore in the quarter ended March 2026 as against net loss of Rs 2.33 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 5.87 crore in the year ended March 2026 as against net loss of Rs 8.14 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.